diaziquone has been researched along with Cancer of Lung in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, JS; Khan, AH | 1 |
| Baylouny, RA; Bissell, EC; Holiat, SM; Hubert, DD; Smith, WE; Sobel, HJ; Watts, LM; Yazdi, E | 1 |
| Creagan, ET; Eagan, RT; Frytak, S; Nichols, WC | 1 |
| Bruntsch, U; Cavalli, F; Høst, H; Joss, R; Pinedo, H; Renard, G; Rozencweig, M; van Glabbeke, M | 1 |
| Baker, LH; Decker, DA; Haas, CD; Samson, MK | 1 |
| Dicke, KA; Spitzer, G | 1 |
| Abeloff, MD; Camacho, FJ; Chang, AY; Creech, RH; Ettinger, DS; Finkelstein, DM | 1 |
| Camacho, FJ; Chang, AY; Ettinger, DS; Finkelstein, DM; Harper, GR; Marsh, JC; Ruckdeschel, JC; Silber, R; Wolter, JM | 1 |
| Baker, LH; Balcerzak, SP; Rivkin, SE; Stephens, RL; Zidar, BL | 1 |
1 review(s) available for diaziquone and Cancer of Lung
| Article | Year |
|---|---|
Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bone Marrow Diseases; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Transplantation, Autologous | 1986 |
2 trial(s) available for diaziquone and Cancer of Lung
| Article | Year |
|---|---|
Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.
Topics: Aclarubicin; Adult; Aged; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Random Allocation | 1985 |
Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.
Topics: Aclarubicin; Aged; Anaphylaxis; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Mitoxantrone; Naphthacenes | 1985 |
6 other study(ies) available for diaziquone and Cancer of Lung
| Article | Year |
|---|---|
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
Topics: Animals; Antineoplastic Agents; Aziridines; Brain Neoplasms; Central Nervous System; Ependymoma; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Quinones | 1976 |
Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos.
Topics: Animals; Antineoplastic Agents; Asbestos, Serpentine; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mitoxantrone; Models, Animal; Nitrosourea Compounds; Pentostatin; Remission Induction; Survival Analysis; Triazines | 2005 |
Phase II study of diaziquone in patients with advanced carcinoma of the lung.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged | 1984 |
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Blood Cell Count; Bone Marrow Diseases; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Soft Tissue Neoplasms | 1983 |
Phase II clinical evaluation of AZQ in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged | 1984 |
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Topics: Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Sarcoma; Soft Tissue Neoplasms | 1985 |